Affirm Launches "AdaptAI" – its AI-Powered Promotions Platform
Article content
Article content
SAN FRANCISCO — Affirm (NASDAQ: AFRM), the payment network that empowers consumers and helps merchants drive growth, today announced it is introducing 'AdaptAI,' its AI-powered promotions platform, to its merchant partners. AdaptAI has enabled Affirm to deliver personalized financial benefits – such as exclusive APR rates, special repayment terms, and immediate cash savings – directly to consumers via the Affirm App and Affirm Card. Now, merchants can deliver these same targeted, real-time promotions and credit offers, which are optimized specifically for a customer's shopping preferences, spending habits, and purchase details, at the point of purchase.
Article content
'Unlike conventional credit card rewards—which are opaque, static, and subsidized by the financially vulnerable—AdaptAI dynamically matches the right benefit to the right consumer at exactly the right moment,' said Vishal Kapoor, Affirm's SVP of Product. 'Consumers no longer need to spend more, keep track of, or wait months to recoup their rewards. Now, they can immediately receive tailored, transparent value at the time of purchase. This is only made possible with Affirm's AI-powered technology and real-time underwriting, and builds on what we do best: delivering customized payment options that help consumers take their money further.'
Article content
Today's consumers expect individualized experiences, especially when paying. Affirm has successfully met this need by offering payment solutions customized to each consumer's purchase and financial profile. Now, thanks to AdaptAI, Affirm's merchant partners can unlock additional value for shoppers right at checkout.
Article content
Each of these bespoke offers translates into tangible consumer value, such as significant savings or added flexibility. Consider a $500 purchase: A merchant using AdaptAI could offer a first-time shopper a 0% APR promotion over 12 months, potentially saving that customer about $120 in interest compared to typical revolving credit card costs. Alternatively, that same merchant could offer its most loyal customers–who Affirm knows value predictability and more time to pay–an interest-bearing offer with extended repayment terms, tied to an event such as a Memorial Day sale. For these customers, spreading a $500 purchase out over 24 months at 10% APR might better align with their budgeting preferences, despite the added cost of about $4 per month in simple interest. This AI-driven nuance can allow merchants to meaningfully reward customers based on their real-time needs, boosting customer satisfaction and loyalty, and ultimately driving greater engagement and conversion.
Article content
Affirm has leveraged AdaptAI across its own consumer products, including the Affirm App and Affirm Card, driving nearly 10% incremental improvements in conversion rates. Building on this proven success, Affirm is now making this powerful AI-powered promotions platform broadly available for its merchant partners.
Article content
Merchants interested in offering these tailored benefits to their customers can get in touch here.
Article content
About Affirm
Affirm's mission is to deliver honest financial products that improve lives. By building a new kind of payment network — one based on trust, transparency, and putting people first — we empower millions of consumers to spend and save responsibly, and give thousands of businesses the tools to fuel growth. Unlike most credit cards and other pay-over-time options, we never charge any late or hidden fees. Follow Affirm on social media: LinkedIn | Instagram | Facebook | X.
Article content
Rates from 0–36% APR. For example, a $800 purchase might cost $72.21/mo over 12 months at 15% APR. Payment options through Affirm are subject to an eligibility check, may not be available everywhere, and are provided by these lending partners: affirm.com/lenders. Options depend on your purchase amount, and a down payment may be required. CA residents: Loans by Affirm Loan Services, LLC are made or arranged pursuant to a California Financing Law license. For licenses and disclosures, see affirm.com/licenses.
Article content
Article content
Article content
Article content
Article content
Article content
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Market Online
6 days ago
- The Market Online
Buzz on the Bullboards: Bombardier vs Boeing, MediPharm 'under attack'
Even with Wall Street operating on a shortened schedule due to the Memorial Day holiday, the TSX has shown resilience—hitting fresh highs twice this week. This bullish momentum underscores the strength and diversity of Canadian equities, particularly in sectors like pharmaceuticals, aerospace, and advanced manufacturing. Among the standout performers are three companies capturing investor attention with bold moves and strategic milestones: MediPharm Labs, Bombardier, and PyroGenesis. MediPharm Labs (TSX:LABS, Forum), a pharmaceutical business in precision-based cannabinoids, has announced the commencement of production for its novel cannabis metered dose inhalers (MDIs) aimed at the European Union and United Kingdom markets. These discreet, smoke-free devices offer patients a fast-acting, pharmaceutical-grade alternative to traditional cannabis consumption methods. What the 'Buzz' Our Bullboards have up to 2 million pageviews a day. Get the inside scoop on conversations around the most significant trends and stock appreciations in our weekly wrap up. Get 'Buzz on the Bullboards' delivered to your inbox every third Thursday! Buzz on the Bullboards | Sign Up Here Manufactured under stringent Good Manufacturing Practices (GMP), the MDIs are distributed exclusively by Blackpoint Ltd., MediPharm's regional partner. The company has already launched the product in Canada and anticipates further rollouts in Australia, the EU, and the UK by Q3 2025. This expansion comes on the heels of a $4.5 million cash sale of its Hope facility, a move aimed at streamlining operations. However, internal turbulence looms. A proxy battle with dissident shareholder Apollo Technology Capital Corp. has raised concerns about governance and financial stability. Despite these headwinds, MediPharm reported an 11 per cent revenue increase in Q1, signaling operational momentum amid strategic uncertainty. MediPharm published a response, calling Apollo Capital 'dissidents' and they 'do not believe they are the well-intentioned and successful business leaders they portray themselves to be', saying the company is currently 'under attack'. Bombardier (TSX:BBD, Forum) has reached a major milestone in its Global 8000 program, with the first production aircraft completing its inaugural flight on May 16. Departing from the company's Aircraft Assembly Centre in Mississauga, Ontario, the flight marks a pivotal step toward the aircraft's entry into service in the second half of 2025. The Global 8000 is positioned as the next evolution of the Global 7500, offering a top speed of Mach 0.94 and an industry-leading range of 8,000 nautical miles. It's designed to connect global cities like Singapore to Los Angeles and London to Perth without refueling, while also offering access to shorter runways typically reserved for smaller jets. Inside, the aircraft redefines luxury with four true living spaces, a dedicated crew rest area, and the lowest cabin altitude in its class. With over 250,000 flight hours logged by the Global 7500, Bombardier's latest innovation is poised to capture a significant share of the ultra-long-range business jet market. Advanced materials innovator PyroGenesis (TSX:PYR, Forum) has secured a major endorsement from aerospace giant Boeing (NYSE:BA, Forum). The company's Ti64 'coarse' metal powder—used in additive manufacturing—has been officially approved and added to Boeing's qualified supplier list. This qualification is a significant validation of PyroGenesis' proprietary plasma atomization technology, which produces high-purity metal powders for 3D printing in aerospace and defense applications. The approval opens the door to broader adoption of PyroGenesis' materials in Boeing's manufacturing ecosystem, potentially unlocking new revenue streams and long-term contracts. As the aerospace industry increasingly turns to additive manufacturing for lightweight, high-performance components, PyroGenesis is well-positioned to benefit from this structural shift. These three TSX-listed companies—MediPharm Labs, Bombardier, and PyroGenesis—are each making headlines for different reasons, from product innovation and international expansion to strategic partnerships and shareholder activism. While the TSX continues to climb, investors would be wise to dig deeper into these stories, assess the risks and opportunities, and consider how these developments align with their investment goals. As always, thorough due diligence remains the cornerstone of smart investing. For previous editions of Buzz on the Bullboards, click here. Join the discussion: Find out what everybody's saying about these stock on Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
National Post
6 days ago
- National Post
Affirm expands partnership with Williams-Sonoma, Inc. into Canada
Article content Article content TORONTO — Affirm (NASDAQ: AFRM), the payment network that empowers consumers and helps merchants drive growth, today announced the expansion of its partnership with Williams-Sonoma, Inc. (NYSE: WSM) into Canada. This builds on the companies' multi-year partnership in the U.S. and brings Affirm to Canadians shopping at Williams-Sonoma, Inc.'s family of brands including Williams Sonoma, West Elm, Pottery Barn, Pottery Barn Teen, Pottery Barn Kids, and Mark & Graham. Article content Whether shopping for a sofa at their local West Elm or furnishing a new nursery with Pottery Barn Kids, approved Canadian shoppers can now split their purchases into monthly payments with Affirm. The process is simple: after selecting Affirm at checkout, consumers go through a quick, real-time eligibility check. If approved, they can choose the customized payment plan that best suits their needs and rest assured that they will never pay any late or hidden fees. Article content 'As Canadian consumers continue to embrace smarter and more flexible ways to manage spending on home furnishings and essentials, Affirm has become a go-to choice for greater payment control and transparency,' said Wayne Pommen, Chief Revenue Officer at Affirm. 'We're thrilled to build on our successful collaboration with Williams Sonoma and their family of brands to bring more Canadians the financial clarity, flexibility, and peace of mind they deserve.' Article content With this launch, Williams-Sonoma, Inc. and its family of brands join leading Canadian retailers, including Amazon, Apple, Samsung, Brown's Shoes, and more in offering Affirm's payment solutions to their customers. Article content Affirm's mission is to deliver honest financial products that improve lives. By building a new kind of payment network—one based on trust, transparency, and putting people first—we empower millions of consumers to spend and save responsibly, and give thousands of businesses the tools to fuel growth. Unlike most credit cards and other pay-over-time options, we never charge any late or hidden fees. Follow Affirm on social media: LinkedIn | Instagram | Facebook | X. Article content Rates from 0-31.99% APR (subject to provincial regulations). Payment options through Affirm Canada Holdings Ltd. ('Affirm') are subject to an eligibility check and depend on purchase amount, vary by merchant, and may not be available in all provinces/territories. A down payment (or a payment due today) may be required. Article content Article content Article content Article content Article content Article content
Globe and Mail
7 days ago
- Globe and Mail
Disney Hits Box Office Highs with Lilo & Stitch - Is DIS Stock a Buy Now?
The Walt Disney Company's (DIS) hit movie ' Lilo & Stitch ' made box office highs on Memorial Day weekend. So, is DIS stock a buy here? Yes - a quick look at its strong free cash flow profile and revenue forecasts shows it could be 24% or so undervalued, worth over $139 per share. DIS is at $112.54 in midday trading on Tuesday, May 27. That is well up from recent lows but only slightly lower than 6-month highs. On May 26, Rotten Tomatoes reported that Lilo & Stitch ' Roars to Highest Memorial Day Weekend Ever.' It is estimated to have grossed $183 million for the long weekend, beating out Paramount's 'Mission: Impossible' film. That implies Disney's cash flow strength seen last quarter could continue this quarter and the fiscal year ending Sept. 2025. This article will look at this. Free Cash Flow Estimates On May 7, Disney reported that its fiscal Q2 ended March 29, revenue was up 7% YoY, and it generated 15% higher operating income. More importantly, its free cash flow (FCF) and FCF margins (i.e., FCF/revenue) surged, as seen in the table below (taken from page 3 of its quarterly earnings release). This shows that FCF was up over double in the quarter, and its FCF margins almost doubled to 20.7%. Moreover, for the past 6 months, it converted 11.65% of revenue into free cash flow. We can use that to estimate its FCF going forward. For example, analysts now expect revenue for this FY ending Sept. 30, 2025, will rise by 2.8% from $92.5 billion last year to $95.11 billion. In addition, forecasts for the next fiscal year are for +5.1% higher revenue of $99.98 billion (almost $100 billion). If it keeps generating hits like Lilo & Stitch, that could happen. That implies that Disney will be on a next 12-month (NTM) run rate revenue of about $97.5 billion. So, if the company can keep generating an FCF margin between 12% and 20% (average of 16%) over that period, here is the FCF forecast: $97.5 billion x 16% FCF margin = $15.6 billion FCF As a result, DIS stock could be worth significantly more. Let's estimate its price target. Target Price for DIS Stock For example, using a 5.0% FCF yield metric (i.e., which assumes that 100% of FCF is paid out to shareholders and the market gives the stock a 5% dividend yield), DIS stock is worth much more than its price today. Let's see how that works. This means that we take the FCF estimate and divide it by 5% (which is the same as multiplying by the reciprocal, or 20x): $15.6 b FCF x 20 = $312 billion market cap That is 54% higher than today's market cap of $202 billion. In other words, DIS stock is worth 54% more or $112.54 x 1.54 = $173 per share However, just to be conservative, let's scale back our parameters. Let's assume that FCF margins stay low at 12.5% and the company generates lower FCF: 0.125 x $97.5 billion NTM revenue = $12.19 billion FCF Next, using a lower FCF multiple of just 18.2 times (i.e., a FCF yield of 5.50%): $12.19b FCF x 18.2 = $221.9 billion mkt cap That is just 10% higher than today's $202 billion market valuation. It means the target price would be $123.79 per share. Expected Return. So, on average, that implies that Disney's valuation could range between $222 billion and $312 billion, or $124 to $173 p/sh (i.e., an average of $148.50). However, the expected return might be lower if we weight the lower target price higher. For example, let's say there is a 2/3rds likelihood DIS stock is worth $123 vs. a 1/3rd chance it's worth $173: $123 x 0.667 = $82.04 + $173 x 0.333 = $57.61 = Target Price = $139.65 Expected Return = $139.65 / $112.54 -1 = 1.24 -1 = +24% Summary So, assuming Disney generates FCF margins this year and next of between 12% and 20% and weighting that possibility heavier on the lower side, an investor can expect around a 24% return investing in DIS stock today at over $139 per share Analysts tend to agree with this target price. For example, Yahoo! Finance reports that 31 analysts have an average price of $123.90. Similarly, Barchart's mean survey is for 125.73. which tracks recent analyst recommendations, shows that the average of 27 analysts is $129.41 per share. That is +15% higher than today's price. The bottom line here is that DIS still looks undervalued, using a FCF and FCF margin analysis, a FCY yield valuation metric, expected return analysis, and also analysts' price targets.
